Intelligent Investment
Melbourne Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read
Overview
- Melbourne is the leading hub for life sciences in Australia, providing a comprehensive ecosystem of cutting-edge biotechnology, pharmaceuticals, medical research, healthcare innovation and manufacturing.
- The City of Melbourne hosts 41% of Australia’s life sciences companies and comprises 60% of Australian pharmaceutical exports. The state of Victoria leads Australia in clinical trials, with over 3,113 ongoing studies.
- World-class research facilities like the Australian Synchrotron and the Aikenhead Centre for Medical Discovery drive the innovation ecosystem, while advanced manufacturing facilities for global life sciences companies enhance Melbourne’s industry capacity.
- Australia’s population aged 65 and over is projected to grow by 54%, from around 4.31 million now to 6.66 million by 2041. The aging population drives investment and development within the sector.
- Melbourne’s research institutions attract about $500 million in medical research funding per year.
Submarkets
- Melbourne Biomedical Precinct (MBP): Over 40 hospitals, medical research institutes, biotechnology organizations and universities. Notable institutions include the University of Melbourne, the Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research. It consistently attracts around 23% of Australia’s annual competitive research funding.
- Parkville Precinct: Home to The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and the Murdoch Children’s Research Institute. Strong ties with the University of Melbourne and other local research entities, including advanced facilities like the Bio21 Institute, which supports interdisciplinary research in biotechnology and molecular science.
- Clayton Precinct: Includes Monash University, the Australian Synchrotron, and the Monash Health Translation Precinct.
Industry Presence
- The life sciences industry supports over 100,000 direct and indirect jobs in Victoria.
- More than 7 out of 10 of Australia’s leading biotech and medtech companies are based in Melbourne.
- The Victorian Government has made substantial financial commitments to support the life sciences sector, including the Breakthrough Victoria Fund, the Victorian Medical Research Acceleration Fund (VMRAF) and various R&D tax incentives to foster innovation and growth.
Life Sciences Venture Capital Investment Trends
Figure 1: Melbourne Life Sciences Venture Capital Funding
- Bristol Myers Squibb
- CSL Behring
- Ena Respiratory
- GSK
- IQVIA
- Johnson & Johnson
- Nutromics
- Pfizer
- Telix Pharmaceuticals
- Thermo Fisher Scientific
- La Trobe Institute for Molecular Science
- Monash University
- St Vincent’s Hospital Melbourne
- The University of Melbourne
Global Life Science Markets
-
Spearheaded by its capital Hyderabad, the state of Telangana has emerged as a pivotal contributor to India’s life sciences landscape.
-
Singapore is one of the few markets in Asia-Pacific with a full end-to-end value chain—manufacturing, research and development (R&D), sales and logistics.
-
Sydney is home to the largest share of life sciences firms in Australia, many of which are among the world’s leading biopharmaceutical companies.